started · updated
South Korea eases import restrictions on obesity drugs
Starting November 12, South Korea has eased regulations to allow travelers to personally carry up to a three-month supply of legally prescribed obesity medications, such as Wegovy and Mounjaro, into the country. The Ministry of Food and Drug Safety and the Korea Customs Service announced that individuals may bring up to six bottles, or a quantity corresponding to a three-month dosage, provided the drugs were obtained through legitimate medical systems abroad.
The policy change aims to resolve previous issues where travelers faced customs delays even with valid prescriptions. The new rules apply to medications prescribed during travel, medications taken by students or residents living abroad, and leftover doses brought back after traveling. However, direct overseas online purchases, narcotics, and psychotropic substances remain strictly prohibited.
The relaxation has sparked concerns regarding “Sushizaro,” a term describing travelers visiting Japan to purchase Mounjaro due to significantly lower costs compared to South Korea. While the move may reduce customs friction, health authorities are monitoring for potential increases in overseas prescription tourism and have issued safety warnings regarding side effects like non-arteritic anterior ischemic optic neuropathy (NAION), which can cause sudden vision loss.
Entities
Japan · Korea Customs Service · Ministry of Food and Drug Safety · South Korea · Wegovy